Center Laboratories, Inc. (TPEX:4123)
Taiwan · Delayed Price · Currency is TWD 37.05
-0.90 (-2.37%)
Aug 11, 2025, 1:30 PM CST
Blueprint Medicines Market Cap
Center Laboratories has a market cap or net worth of 27.03 billion as of August 8, 2025. Its market cap has decreased by -30.27% in one year.
Market Cap
27.03B
Enterprise Value
31.34B
Revenue
1.63B
Ranking
n/a
PE Ratio
n/a
Stock Price
$37.05
Market Cap Chart
Since November 3, 2004, Center Laboratories's market cap has increased from 358.01M to 27.03B, an increase of 7,450.00%. That is a compound annual growth rate of 23.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 27.03B | -14.44% |
| Dec 31, 2024 | 31.59B | 3.14% |
| Dec 29, 2023 | 30.63B | 8.88% |
| Dec 30, 2022 | 28.13B | -7.93% |
| Dec 30, 2021 | 30.56B | -3.72% |
| Dec 31, 2020 | 31.74B | 30.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 57.98B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.81B |
| Pegavision | 24.80B |
| Lumosa Therapeutics | 23.97B |